Fig. 2From: Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case reportPatient’s percent level of methemoglobin relative to normal hemoglobin based on sequential complete blood-cell counts with differentialBack to article page